Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

ENCORAFENIB (BRAFTOVI) 75 mg Capsules

Northern Health and Social Care Trust

This public procurement record has 2 releases in its history.

Award

17 Aug 2026 at 14:22

UK6 - Contract Award Notice
Award

17 Aug 2026 at 14:16

UK5 - Transparency Notice
Summary of the contracting process

Northern Health and Social Care Trust procured the supply of ENCORAFENIB (BRAFTOVI) 75 mg capsules, a pharmaceutical product used within the Trust’s health and social care services. The requirement covers supply of the specified medicine for delivery in the United Kingdom, with the buying organisation based at Antrim Area Hospital in Antrim. This is a goods procurement rather than a service or works contract. The named supplier is PIERRE FABRE LIMITED, a large pharmaceutical company based in London. The requirement is tightly defined around one branded medicine and its 75 mg capsule presentation, so it is relevant primarily to manufacturers, marketing authorisation holders, or authorised pharmaceutical suppliers able to provide this exact product through appropriate healthcare supply arrangements.

The procurement is complete and has been awarded through a direct award. PIERRE FABRE LIMITED was selected as supplier on 17 August 2026 for the single lot. The award value is £180,000 excluding VAT, or £216,000 including VAT. The contract period runs from 1 September 2026 to 31 August 2029. A scheduled signature milestone is due by 31 August 2026, and the standstill period ends on 28 August 2026. The Trust justified the direct award because the medicine is patent-protected and commercially available from one supplier as sole marketing authorisation holder, with no reasonable alternative or substitute. The process was above the relevant threshold and used the exclusive-rights single-supplier rationale.

This award demonstrates a defined requirement for a specialist oncology medicine within Northern Health and Social Care Trust’s purchasing activity. A business seeking to compete when this requirement next returns would need to hold, or have authorised access to, the relevant intellectual property and marketing authorisation for ENCORAFENIB (BRAFTOVI) 75 mg capsules. It would also need dependable pharmaceutical distribution arrangements capable of supplying the specified presentation to a UK healthcare buyer. The procurement route indicates that exclusivity, legal rights and the absence of clinically or commercially reasonable substitutes are decisive factors. General pharmaceutical capability alone would not make a supplier credible if it could not lawfully provide this exact patented product.

How relevant is this notice?

Notice Information

Notice Title

ENCORAFENIB (BRAFTOVI) 75 mg Capsules

Notice Description

Contract for supply of ENCORAFENIB (BRAFTOVI) 75 mg Capsules for a period of up to 3 years

Procurement Information

Purchase of drugs which are subject to patent protection/ Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods,services or works. The product required is only commercially available from one supplier and no competition or alternative exists for this product.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e5aa
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/078142-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£180,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
17 Aug 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
17 Aug 20261 weeks ago
Contract Period
1 Sep 2026 - 31 Aug 2029 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Northern Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
ANTRIM
Postcode
BT41 2RL
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0D Antrim and Newtownabbey
Delivery Location
Not specified
Local Authority
Antrim and Newtownabbey
Electoral Ward
Springfarm
Westminster Constituency
South Antrim

Supplier Information

Number of Suppliers
1
Supplier Name

PIERRE FABRE LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...